Standard & Poors (S&P) will announce their December reweighting of the ASX200 today at 5.10pm and Imugene will be admitted into this index.
Actual admission of new companies (and deletion of some existing companies) onto the ASX200 will take place on 17 December 2021.
Make no mistake, these changes are critically important for Imugene both on the domestic and international stage, and validate the company's position today as Australia's largest pure biotech company.
The positive impact of this historic S&P recognition, both on the company's share price and on its global standing, should not be underestimated.
Standard & Poors (S&P) will announce their December reweighting...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
-0.001(1.85%) |
Mkt cap ! $394.1M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.5¢ | 5.2¢ | $1.975M | 36.88M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 4400559 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 1340583 | 5 |
View Market Depth
| Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |